The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest colorectal cancer drugs market share, and Middle East was the fastest-growing region in 2022.

The global colorectal cancer drugs market is expected to grow from $13.65 billion in 2022 to $14.21 billion in 2023 at a compound annual growth rate (CAGR) of 4.1%. The global colorectal cancer drugs market size is expected to grow to $16.22 billion in 2027 at a CAGR of 3.3%.

Major Driver In The Colorectal Cancer Drugs Market ­– Increase In Number Of Cases Of Colorectal Cancer Worldwide
According to study published in ACS Publications, a US-based scientific magazine, 147,950 people will be diagnosed with CRC in March 2020, and 53,200 will die from it, based on data from the National Centre for Health Statistics. People under the age of 50 will account for 17,930 of these illnesses and fatalities. The number of colorectal cancer event cases is anticipated to rise by 27.3% to 672,400 by 2037. This rise can be ascribed to causes such as a low-fiber diet, obesity, and the use of alcohol and tobacco, among others. The growing number of colorectal cancer cases will boost the size of the global colorectal cancer medication market.

View More On The Colorectal Cancer Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Key Colorectal Cancer Drugs Market Segments
1) By Type: Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators
2) By Distribution Channels: Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels
3) By Class: Immunotherapy, Chemotherapy, Other Classes

Recent Colorectal Cancer Drugs Market Trend – Adopting Targeted Therapies
When compared to chemotherapy alone, targeted medicines have already begun to lengthen the lives of patients with metastatic colorectal cancer. Hormone therapies, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery agents are examples of target therapies. Because of its sensitivity towards cancer cells while avoiding damage to off-target cells, targeted therapy is gaining popularity. Targeted therapy include Opdivo and Keytruda.

Colorectal Cancer Drugs Market Prominent Players
Major players in the colorectal cancer drugs market are Merck & Co. Inc., Roche, Sanofi, Amgen, Pfizer Inc., Abbott Laboratories, Taiho Pharma, Novartis, GlaxoSmithKline, Onyx, TAKEDA PHARMACEUTICALS, Bristol-Myers Squib, Sumitomo Dainippon Pharma, Array BioPharma, Eli Lilly, RANDOX LABORATORIES, Suzhou Zelgen Biopharmaceuticals, Beckman Coulter Inc., Regeneron, EDP Biotech, Genomic Tree, Metabiomics Corporation, SIEMENS HEALTHCARE, Suzhou Zelgen Biopharmaceuticals, Sumitomo Dainippon Pharma and EPIGENOMICS.

Request A Sample Of The Global Colorectal Cancer Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2590&type=smp

The Colorectal Cancer Drugs Global Market Report 2023  provides a comprehensive overview on the colorectal cancer drugs market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the colorectal cancer drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Colorectal cancer (CRC) is a kind of cancer that affects the large intestine and the rectum. They are also termed as colon tumours or rectal cancer depending on where they begin.

View More Related Reports –
Drugs For Erectile Dysfunction Global Market Report 2023
Cancer Biologics Global Market Report 2023
Cancer Diagnostics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model